Read + Share
Amedeo Smart
Independent Medical Education
Bockorny B, Bullock AJ, Abrams TA, Faintuch S, et al. Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma. Dig Dis Sci 2021 Jul 23. pii: 10.1007/s10620-021-07156.PMID: 34297268
Email
LinkedIn
Facebook
Twitter
Privacy Policy